2,4-pyridinedicarboxylic acid has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CC; Chen, TJ; Cheng, HH; Chu, CH; Hsu, KC; Hung, CL; Kung, HJ; Li, LT; Liu, R; Wang, LY; Wang, SM; Wang, WC; Wu, CM; Yang, JM | 1 |
1 other study(ies) available for 2,4-pyridinedicarboxylic acid and Prostatic Neoplasms
Article | Year |
---|---|
KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor.
Topics: Apoptosis; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Jumonji Domain-Containing Histone Demethylases; Kinetics; Male; Models, Molecular; Molecular Targeted Therapy; Prostatic Neoplasms; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |